Quantitative analysis for Odyssey Therapeutics, Inc. (ODTX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (68.0) (grade B). 26 signals analyzed (23 differentiated alt-data).
ODTX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-08 | $20.30 | $15.35 | $16.42 |
| 2026-05-19 | $17.65 | $16.75 | $16.94 |
| 2026-05-29 | $18.02 | $16.86 | $17.01 |
| 2026-06-09 | $17.55 | $16.93 | $17.09 |
| 2026-06-18 | $19.49 | $17.95 | $19.07 |
| 2026-06-30 | $19.59 | $18.37 | $18.71 |
| 2026-07-10 | $17.30 | $15.50 | $16.69 |
| 2026-07-21 | $18.42 | $17.20 | $18.22 |
| 2026-07-30 | $18.83 | $17.86 | $18.42 |
| 2026-08-10 | $22.43 | $20.80 | $22.17 |
| 2026-08-20 | $24.77 | $23.07 | $24.67 |
| 2026-08-31 | $24.80 | $22.89 | $24.52 |
How Odyssey Therapeutics, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | $486M | — |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $501M | — |
| CBIO | Crescent Biopharma, Inc. | $521M | — |
| OCGN | Ocugen, Inc. | $460M | — |
View all Health Care stocks by valuation and signals →
Odyssey Therapeutics, Inc. (ODTX) scores Buy (68.0), with every measured dimension at or below 30. The weakest are technicals at 30, competitive moat at 27, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 30 |
| competitive moat | 27 |
StoQuant analyzes 26 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Odyssey Therapeutics, Inc. (ODTX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ODTX"><img src="https://stoquant.com/badge/ODTX.svg" alt="Odyssey Therapeutics, Inc. (ODTX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.